Epidemiology, treatment and outcome of candidemia: A five-year review at three Canadian hospitals

Mycoses

Volumn 45, Issue 5-6, 2002, Pages 141-145

  Macphail, G L P ^a   Taylor, G D ^b   Buchanan Chell, M ^b   Ross, C ^a   Wilson, S ^c   Kureishi, A ^a  

^a FOOTHILLS HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c ROYAL ALEXANDRA HOSPITAL   (Canada)

Author keywords

Canada; Candidemia; Epidemiology

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

BLOOD CULTURE; CANADA; CANDIDA ALBICANS; CANDIDEMIA; CANDIDIASIS; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CANADA; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; FEMALE; FUNGEMIA; HOSPITAL BED CAPACITY, 500 AND OVER; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; RISK FACTORS; TREATMENT OUTCOME;

CANDIDA; CANDIDA ALBICANS;

EID: 0036301851     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2002.00741.x     Document Type: Review

References (18)

1. Epidemiology of nosocomial fungal infections
2. Secular trends in the epidemiology of nosocomial fungal infection in the United States. 1980-90
3. Hospital-acquired candidemia
4. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
5. Risk factors for hospital-acquired candidemia: A matched case-control study
6. Risk factors for nosocomial candidemia: A case-control study in adults without leukemia
7. Risk factors for candidemia in cancer patients: A case-control study
8. Increased C. krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
9. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
10. Candida glabrata, Candida krusei, non-albicans Candida spp. and other fungal organisms in a sixty bed national cancer center in 1989-93: No association with the use of fluconazole
11. Resistance of Candida species to fluconazole
12. Therapeutic approaches in patients with candidemia
13. International conference for the development of a consensus on the management and prevention of severe candidal infections
14. Guidelines for the management of nosocomial Candida infections in non-neutropenic intensive care patients
15. CDC definitions for nosocomial infections
16. Candidemia in a Canadian tertiary care hospital for 1976-96
17. Trends and sources of nosocomial fungaemia